PlainRecalls
FDA Drug Low Class III Terminated

Moxifloxacin Ophthalmic Solution USP, 0.5%, 3 mL bottle, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, INDIA, NDC 68180-422-01.

Reported: March 6, 2019 Initiated: February 26, 2019 #D-0517-2019

Product Description

Moxifloxacin Ophthalmic Solution USP, 0.5%, 3 mL bottle, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, INDIA, NDC 68180-422-01.

Reason for Recall

Failed Impurities/Degradation Specifications: Expansion of July 2018 and February 2019 recall due to high out-of-specification for impurities.

Details

Units Affected
674,628 bottles
Distribution
Nationwide in the USA and Puerto Rico.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Moxifloxacin Ophthalmic Solution USP, 0.5%, 3 mL bottle, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, INDIA, NDC 68180-422-01.. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 674,628 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Expansion of July 2018 and February 2019 recall due to high out-of-specification for impurities.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 6, 2019. Severity: Low. Recall number: D-0517-2019.